Compare Capital One Financial Corp. (COF) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capital One Financial Corp. vs Revvity Inc — how do they compare? Capital One Financial Corp. trades at $221.15 (market cap $134.45B), while Revvity Inc trades at $116.39 (market cap $12.91B). The key difference: Capital One Financial Corp. is far larger — about 10.4× Revvity Inc's market cap, and Capital One Financial Corp. pays the higher dividend (1.46%). Which is the better fit depends on your goals.
| COF | RVTY | |
|---|---|---|
Market Cap | $134.45B | $12.91B |
Sector | Financials | Technology |
52-Week High | $257.94 | $117.75 |
52-Week Low | $176.10 | $82.26 |
Dividend Yield | 1.46% | 0.24% |
Enterprise Value | — | $15.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Capital One Financial (COF) trades at $221.20, up 1.02% today, with a bullish technical signal from moving averages but overbought RSI readings near 77. The stock shows strong fundamentals with a P/E of 12.07 and net income margin of 16.96% for 2026, supported by robust Q2 2026 earnings beating estimates. Recent news highlights the Discover integration progress and a 20-year arena naming rights extension, reinforcing brand commitment.
Outlook is positive with a consensus price target of $251.60, implying 14% upside, driven by earnings growth and synergy capture from Discover. Key risks include integration execution, credit loss provisions, and economic sensitivity. The bullish analyst consensus (63% Buy) and institutional holdings suggest confidence in continued performance, though overbought conditions may prompt near-term volatility.
RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.
The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
